N-hydroxy-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-7-ide-3-carboxamide;rubidium(1+)
C10H12N3O2Rb — CID 169125413
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-hydroxy-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-7-ide-3-carboxamide;rubidium(1+)
N-hydroxy-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-7-ide-3-carboxamide;rubidium(1+) (PubChem CID 169125413) has the molecular formula C10H12N3O2Rb and a molecular weight of 291.69 g/mol. Its IUPAC name is N-hydroxy-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-7-ide-3-carboxamide;rubidium(1+).
Molecular Properties
| Compound Name | N-hydroxy-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-7-ide-3-carboxamide;rubidium(1+) |
|---|---|
| PubChem CID | 169125413 |
| Molecular Formula | C10H12N3O2Rb |
| Molecular Weight | 291.69 g/mol |
| Exact Mass | 291.00 |
| IUPAC Name | N-hydroxy-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-7-ide-3-carboxamide;rubidium(1+) |
| SMILES | CN1[CH-]Cc2ncc(C(=O)NO)cc2C1.[Rb+] |
| InChI | InChI=1S/C10H12N3O2.Rb/c1-13-3-2-9-8(6-13)4-7(5-11-9)10(14)12-15;/h3-5,15H,2,6H2,1H3,(H,12,14);/q-1;+1 |
| InChIKey | OUQOVSCRSOWPNI-UHFFFAOYSA-N |
| XLogP | -2.65 |
| TPSA | 65.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 16 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 291.69 |
| LogP ≤ 5 | -2.65 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169125413 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.